Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Curr Oncol ; 26(4): 234-239, 2019 08.
Artículo en Inglés | MEDLINE | ID: mdl-31548802

RESUMEN

Background: Expert groups have recommended incorporation of a geriatric assessment into clinical practice for older patients starting oncologic therapy. However, that practice is not standard primarily because of resource limitations. In the present study, we evaluated the effect on treatment decisions by oncologists in the community oncology setting of a brief geriatric assessment tool that estimates risk of toxicity. Methods: This prospective longitudinal study in 5 community oncology practices in British Columbia involved patients 70 years of age and older starting a new cytotoxic chemotherapy regimen. Clinical personnel completed a brief validated geriatric assessment tool-the Cancer and Aging Research Group chemotherapy toxicity tool (carg-tt)-that estimates the risk of grade 3 or greater toxicity in older patients. Physicians were asked if the carg-tt changed their treatment plan or prompted extra supports. Patients were followed to assess the incidence of toxicity during treatment. Results: The study enrolled 199 patients between July 2016 and February 2018. Mean age was 77 years. Treatment was palliative in 61.4% of the group. Compared with physician judgment, the carg-tt predicted higher rates of toxicity. In 5 patients, treatment was changed based on the carg-tt. In 38.5% of the patients, data from the tool prompted extra supports. Within the first 3 cycles of treatment, 21.3% of patients had experienced grade 3 or greater toxicity. Conclusions: This study demonstrates that use of a brief geriatric assessment tool is possible in a broad community oncology practice. The tool modified the oncologist's supportive care plan for a significant number of older patients undertaking cytotoxic chemotherapy.


Asunto(s)
Antineoplásicos/efectos adversos , Evaluación Geriátrica/métodos , Neoplasias/tratamiento farmacológico , Anciano , Anciano de 80 o más Años , Antineoplásicos/uso terapéutico , Colombia Británica , Toma de Decisiones Clínicas , Femenino , Humanos , Estudios Longitudinales , Masculino , Cuidados Paliativos/estadística & datos numéricos , Estudios Prospectivos , Medición de Riesgo
2.
Ann Oncol ; 24(2): 428-432, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-23035152

RESUMEN

BACKGROUND: The established treatment of limited-stage follicular lymphoma is radiotherapy (RT). There is an inherent risk of transformation of follicular lymphoma to aggressive lymphoma; however, the frequency and impact on the outcome are unknown in limited-stage patients. MATERIALS AND METHODS: We identified 237 patients with limited-stage follicular lymphoma treated with curative intent RT. Cases were reviewed to determine the frequency of transformation and subsequent survival. RESULTS: With a median follow-up of 7.4 years, the 10-year risk of transformation was 18.5%. With a median follow-up after transformation of 4.7 years, the 3-year post-transformation progression-free survival (PFS) and overall survival (OS) were 42% and 44%, respectively. The addition of rituximab improved the 3-year post-transformation PFS and OS compared with combination chemotherapy alone (78% versus 15%, P < 0.00001) and (87% versus 38.5%, P < 0.00001), respectively. In multivariate analysis, only rituximab was associated with OS [HR 0.07 (95% CI 0.015-0.312, P = 0.001)] and PFS [HR 0.19 (95% CI 0.55-0.626, P = 0.007)] following transformation. CONCLUSIONS: There is a moderate risk of transformation in limited-stage follicular lymphoma treated with curative intent RT, and it substantially impacts outcome in these patients. Treatment with rituximab at the time of transformation appears to improve survival in this otherwise poor-risk population.


Asunto(s)
Transformación Celular Neoplásica , Linfoma Folicular/patología , Linfoma Folicular/radioterapia , Anciano , Anciano de 80 o más Años , Anticuerpos Monoclonales de Origen Murino/efectos adversos , Anticuerpos Monoclonales de Origen Murino/uso terapéutico , Terapia Combinada , Supervivencia sin Enfermedad , Femenino , Humanos , Linfoma Folicular/tratamiento farmacológico , Linfoma Folicular/mortalidad , Masculino , Persona de Mediana Edad , Rituximab , Sobrevida , Resultado del Tratamiento
3.
Plant Dis ; 84(3): 372, 2000 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-30841263

RESUMEN

Hemp (Cannabis sativa L.) is a herbaceous annual grown mainly for its blast fiber and seed oil. In 1999, Health Canada issued licenses to plant 12,145 ha of hemp in Canada. Of these, 730 ha were in Alberta. During the last week of August, hemp plants (cv. Fasamo) in a central Alberta field showed the following symptoms and signs: wilting foliage turning light brown; dry tan to gray lesions on stems; shredding and breaking of stems at the lesion; presence of white mycelium in the lesion; and black round, irregular, or oblong sclerotia (up to 5 mm diameter and 2 to 11 mm long) present externally at the lesion on the stem and inside the pith cavity. Lesions were found at the crown, near the inflorescence, and along the entire stem length. Disease incidence in a survey of six commercial fields (40 ha) ranged from 1 to 8%. The organism isolated from lesions on potato dextrose agar produced white aerial mycelia and large numbers of sclerotia characteristic of Sclerotinia sclerotiorum. Pathogenicity was confirmed by inoculating 23-day-old greenhouse-grown hemp plants (cv. Fasamo) with autoclaved wheat grains colonized for 14 days with a S. sclerotiorum culture previously isolated from an infected hemp plant. The grains were placed on soilless growing medium near the plant and covered very lightly. One week after inoculation, grayish lesions appeared on the stems, white mycelia appeared on lesions, and plants wilted. The pathogen was reisolated from the lesions. This is the first report of S. sclerotiorum on hemp in Alberta, Canada. The disease known as hemp canker has been reported to cause severe losses under cool wet conditions in the Netherlands (1). Reference: (1) J. M. McPartland. J. Int. Hemp Assoc. 3:19, 1996.

4.
Plant Dis ; 83(5): 488, 1999 May.
Artículo en Inglés | MEDLINE | ID: mdl-30845551

RESUMEN

In Alberta, powdery mildew disease of greenhouse-grown tomatoes (Lycopersicon esculentum Mill.) appeared for the first time in 1995 as circular white colonies on leaves, petioles, and stems. Since then it has been found every year and is becoming an economically important disease of tomatoes. This is the first report of the disease from Alberta, Canada. In Canada, powdery mildew on greenhouse tomatoes was previously reported in 1994 from the province of Quebec (1). The pathogen had unbranched conidiophores with average length and width of 62.3 µm and 8.5 µm, respectively. Conidia were clear or hyaline, elliptical to oval in shape, and were borne singly or in short chains. Average length and width of conidia were 36.0 µm and 17.6 µm, respectively. The conidia contained numerous vacuoles but fibrosin bodies were not observed. Germ tubes were straight and formed at the ends or very close to the ends of conidia. Rarely, a conidium produced two germ tubes. Cleistothecia were not found. Six-week-old, greenhouse-grown, healthy tomato cv. Trust plants were inoculated by shaking conidia from powdery mildew-infected plants onto the leaves of the healthy plants. The plants developed powdery mildew symptoms within 9 days after the inoculation. The symptoms on inoculated plants and morphological characteristics of the pathogen were similar to those for naturally infected plants. Based on the characteristics of the asexual stage, the pathogen was identified as an Erysiphe sp. until its identity is confirmed by the characteristics of its sexual stage. An Erysiphe sp. has also been reported to cause powdery mildew of greenhouse-grown tomatoes in Canada (1), the U.S. (3), and Spain (2). Optimal temperature and relative humidity for germination of conidia of the pathogen were 20 to 25°C and >90%, respectively. Myclobutanil, fenarimol, sulfur, triademefon, and triforine showed promise for effective management of this disease. Myclobutanil and sulfur are now registered for control of this disease in Canada. Since cleistothecium has not been found, there is a need to identify the sources of primary inoculum to understand the disease cycle and effective management of the disease. References: (1) R. R. Bélanger and W. R. Jarvis. Plant Dis. 78:640, 1994. (2) L. Olalla and J. A. Torés. Plant Dis. 82:592, 1998. (3) J. F. White, Jr., et al. Plant Dis. 81:227, 1997.

5.
Plant Dis ; 81(9): 1011-1014, 1997 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-30861951

RESUMEN

Verticillium wilt (Verticillium albo-atrum) is an important disease affecting potato tuber yield and quality. In North America the major commercial cultivars are susceptible and management strategies for control of the pathogen rely mainly on soil fumigation and crop rotation. In this study 398 genotypes from accessions of Solanum berthaultii, S. chacoense, and S. tarijense were screened for resistance to Verticillium albo-atrum. Resistant genotypes were identified in all but two accessions; however, results indicate that tolerance is more common than resistance. We identified two genotypes in S. chacoense (PI 472819) that had low stem-colonization levels and also did not develop wilt symptoms when inoculated with V. albo-atrum. These genotypes and a susceptible genotype from PI 472810 (S. chacoense) were studied to determine genetic inheritance. Segregation ratios in F1, F2, and backcross populations indicated that resistance in one of the resistant genotypes (18-21R) was controlled by a single dominant gene. Transfer of the Vc gene to tetraploid germ plasm could provide effective and economical control of Verticillium wilt.

6.
Theor Appl Genet ; 89(6): 661-4, 1994 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-24178007

RESUMEN

Resistance to verticillium wilt, a vascular disease causing yield losses in many crops, is conferred in tomato by a single dominant allele, Ve. A population segregating for the Ve allele was generated using near-isogenic tomato lines. Analysis of the parental tomato DNA using the polymerase chain reaction and 400 random primers, each 10 deoxyribonucleotides in length, produced 1,880 amplified DNA fragments. Of the four polymorphisms observed between the resistant and susceptible parental genotypes, only one was linked to the Ve gene. No recombination was observed between this DNA marker and the Ve locus, indicating that the linkage is less than 3.5±2.7 cM. The marker detected both the susceptible and resistant alleles, producing amplified DNA fragments of approximately 1,300 and 1,350 bp, respectively. The sequence of the primer, determined from cloned amplified products, was 5' CTCACATGCA 3' instead of the expected 5' CTCACATGCC 3'. The marker will be of value to tomato breeding programs because of the tight linkage, Codominant nature, and analytical procedure utilized.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...